Last week at Scope Summit Europe, Continuum Clinical, A Spectrum Science Company explored the evolving landscape of clinical trials and patient engagement. Check out the top 5 takeaways on decentralization, patient-centered protocol design, diversity in trials and more!?
Returning from SCOPE Europe, Stephen O'Farrell and Neil Weisman reflect on the "significant value left unrealized" in the clinical trial process - especially as trial operations get more complex - and propose a better way forward.